HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heavy-atomic construction of photosensitizer nanoparticles for enhanced photodynamic therapy of cancer.

Abstract
A new type of heavy-atom-affected Pluronic (F-127) nanoparticle (FIC NP) for photodynamic therapy (PDT) is reported. FIC NPs are formulated with biocompatible constituents, and contain densely integrated iodinated aromatic molecules that form a structurally rigid core matrix and stably encapsulate photosensitizers in a monomeric form. Tiny nanoparticles (≈10 nm) are prepared by aqueous dispersion of photosensitizer-embedded aromatic nanodomains, which self-assemble by phase separation from the Pluronic melt mixture. By using spectroscopic studies and cellular experiments, the following is demonstrated: 1) enhanced singlet-oxygen generation by means of the intraparticle heavy-atom effect on the embedded photosensitizer, 2) facilitated cell uptake due to the small nanoscopic size as well as the Pluronic surface characteristics, and thereby 3) actual enhancement of PDT efficacy for a human breast-cancer cell line (MDA-MB-231), which validates a photophysically motivated nanoformulation approach toward an advanced photosensitizing nanomedicine.
AuthorsChang-Keun Lim, Jiyoung Shin, Yong-Deok Lee, Jungahn Kim, Hoyong Park, Ick Chan Kwon, Sehoon Kim
JournalSmall (Weinheim an der Bergstrasse, Germany) (Small) Vol. 7 Issue 1 Pg. 112-8 (Jan 03 2011) ISSN: 1613-6829 [Electronic] Germany
PMID21132707 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Photosensitizing Agents
Topics
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Humans
  • Nanoparticles (chemistry)
  • Neoplasms (drug therapy)
  • Photochemotherapy (methods)
  • Photosensitizing Agents (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: